StockMacro
Menu

Jon Halbert

Insider (Form 4 reporting owner): Director CIK 1189394Name as filed: HALBERT JONIts filings on EDGARAll insiders

Measures activity, not value. Not investment advice.

Since 15 May 2026, bought $990K in 1 open-market purchase of Caris Life Sciences.

Companies

Role on the latest Form 4 for each; open-market trades counted
CompanyRoleTrades fromtoPurchasesSales
Caris Life Sciences CAIDirector15 May 202615 May 20261$990K–

What the share price did after their trades Share price return after each open-market trade, from the first close after the Form 4 became public, minus the return of the company's sector fund (the S&P 500 fund when the sector has none) over the same days. Median over the trades, in percentage points; at most one trade per company, side and month. It describes the past.

Median return minus the sector fund, in percentage points; "too few trades" under 5
Open-market tradesAfter 3 monthsAfter 6 monthsAfter 12 months
After purchasestoo few trades1 tradeno trade old enoughno trade old enough

For a sale, a negative number means the shares did worse than the sector afterwards. It describes the past, not what comes next.

By year

Counted open-market trades, by trade date
YearPurchasesBoughtSalesSoldNet
20261$990K––$990K

Every trade

1, newest first; open-market purchases and sales only
Trade dateCompanySideSharesPriceValuePlanned Rule 10b5-1 plan: the insider set the trade up in advance, so its timing says less about their view. The box exists on Form 4 since April 2023. Filing
15 May 2026Caris Life Sciences CAIBuy68,000$14.56$990KNoForm 4filed 13 Jul 2026

From Form 4: open-market purchases (code P) and sales (code S) only; awards, option exercises, tax withholding and gifts are not counted. Greyed rows are amended copies or another filer's report of the same trade and count nowhere. Measures activity, not value. Not investment advice.